propafenone has been researched along with Porphyria, Variegate in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Porphyria, Variegate: An autosomal dominant porphyria that is due to a deficiency of protoporphyrinogen oxidase (EC 1.3.3.4) in the LIVER, the seventh enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, COPROPORPHYRINS and protoporphyrinogen.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rodríguez-Suárez, S | 1 |
García-Morillo, S | 1 |
Gómez-Morales, L | 1 |
Romero-Rodriguez, N | 1 |
Beltran-Romero, L | 1 |
Gonzalez-Estrada, A | 1 |
1 other study available for propafenone and Porphyria, Variegate
Article | Year |
---|---|
Variegate porphyria and atrial fibrillation: acute attack induced by propafenone.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Inappropriate ADH Syndrome; Male; Porphy | 2012 |